Jason Bablak
Chief Operating Officer at Attune Pharmaceuticals, Inc.
Jason Bablak active positions
Companies | Position | Start | End |
---|---|---|---|
Attune Pharmaceuticals, Inc.
Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Attune Pharmaceuticals, Inc. engages in the provision of biotechnology services. It discovers and develops orally-administered small-molecule therapeutics for the treatment of rare diseases. The company was founded by Andrew Ian McDonald and is headquartered in New York, NY. | Chief Operating Officer | - | - |
Career history of Jason Bablak
Former positions of Jason Bablak
Companies | Position | Start | End |
---|---|---|---|
Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company was founded on July 21, 2003 and is headquartered in New York, NY. | General Counsel | 2003-12-31 | - |
Immune Deficiency Foundation | General Counsel | 1999-12-31 | 2002-12-31 |
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | General Counsel | 1996-12-31 | 1999-12-31 |
Popham Haik, Schnobrich & Kaufman Ltd. | Corporate Officer/Principal | 1992-12-31 | 1994-12-31 |
Thar Pharmaceuticals, Inc.
Thar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thar Pharmaceuticals, Inc. operates as a specialty pharmaceutical company. The firm focuses on transforming intravenous drugs into oral drugs for existing and new indications. The company was founded by Mazen Hanna and Raymond K. Houck and is headquartered in Pittsburgh, PA. | General Counsel | - | - |
Primaryimmune Services, Inc. | General Counsel | - | - |
Training of Jason Bablak
Allegheny College | Undergraduate Degree |
University of Pittsburgh Law School | Graduate Degree |
Statistics
International
United States | 10 |
Operational
General Counsel | 5 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 3 |
Commercial Services | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 7 |
---|---|
Thar Pharmaceuticals, Inc.
Thar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thar Pharmaceuticals, Inc. operates as a specialty pharmaceutical company. The firm focuses on transforming intravenous drugs into oral drugs for existing and new indications. The company was founded by Mazen Hanna and Raymond K. Houck and is headquartered in Pittsburgh, PA. | Health Technology |
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | Commercial Services |
Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company was founded on July 21, 2003 and is headquartered in New York, NY. | Health Technology |
Popham Haik, Schnobrich & Kaufman Ltd. | |
Attune Pharmaceuticals, Inc.
Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Attune Pharmaceuticals, Inc. engages in the provision of biotechnology services. It discovers and develops orally-administered small-molecule therapeutics for the treatment of rare diseases. The company was founded by Andrew Ian McDonald and is headquartered in New York, NY. | Commercial Services |
Immune Deficiency Foundation | Miscellaneous |
Primaryimmune Services, Inc. |
- Stock Market
- Insiders
- Jason Bablak
- Experience